Mitchell A Nides1, Scott J Leischow2, Meghna Bhatter2, Michael Simmons2. 1. Los Angeles Clinical Trials, Burbank, CA. Scott J. Leischow, Mayo Clinic, Scottsdale, AZ, USA. mnides@laclinicaltrials.com. 2. Los Angeles Clinical Trials, Burbank, CA. Scott J. Leischow, Mayo Clinic, Scottsdale, AZ, USA.
Abstract
OBJECTIVES: To evaluate nicotine delivery from the NJOY® King Bold Electronic Nicotine Delivery System (ENDS) and its short-term potential for smoking reduction or cessation. METHODS: One week of ad libitum use was followed by measurements of plasma nicotine, heart rate, and craving and withdrawal after 12 hours of nicotine abstinence in 25 adult smokers not interested in quitting. RESULTS: After 5 minutes of use, blood nicotine levels increased by a mean of 3.5 ng/mL (p < .001), heart rate increased, and craving was reduced by 55%. Cigarettes per day were reduced by 39% during the test week, and perceptions of use for reduction or cessation were positive. CONCLUSIONS: The NJOY® King Bold ENDS delivers nicotine and led to short-term smoking reduction.
OBJECTIVES: To evaluate nicotine delivery from the NJOY® King Bold Electronic Nicotine Delivery System (ENDS) and its short-term potential for smoking reduction or cessation. METHODS: One week of ad libitum use was followed by measurements of plasma nicotine, heart rate, and craving and withdrawal after 12 hours of nicotine abstinence in 25 adult smokers not interested in quitting. RESULTS: After 5 minutes of use, blood nicotine levels increased by a mean of 3.5 ng/mL (p < .001), heart rate increased, and craving was reduced by 55%. Cigarettes per day were reduced by 39% during the test week, and perceptions of use for reduction or cessation were positive. CONCLUSIONS: The NJOY® King Bold ENDS delivers nicotine and led to short-term smoking reduction.
Authors: Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski Journal: J Neurosci Methods Date: 2019-10-12 Impact factor: 2.390
Authors: Jonathan Foulds; Susan Veldheer; Jessica Yingst; Shari Hrabovsky; Stephen J Wilson; Travis T Nichols; Thomas Eissenberg Journal: Nicotine Tob Res Date: 2014-10-19 Impact factor: 4.244
Authors: Lila J Finney Rutten; Kelly D Blake; Amenah A Agunwamba; Rachel A Grana; Patrick M Wilson; Jon O Ebbert; Janet Okamoto; Scott J Leischow Journal: Nicotine Tob Res Date: 2015-01-14 Impact factor: 4.244
Authors: Travis T Nichols; Jonathan Foulds; Jessica M Yingst; Susan Veldheer; Shari Hrabovsky; John Richie; Thomas Eissenberg; Stephen J Wilson Journal: Brain Res Bull Date: 2015-10-23 Impact factor: 4.077